Cargando…
Letter to Editor on "A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India"
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040503/ https://www.ncbi.nlm.nih.gov/pubmed/35487344 http://dx.doi.org/10.1016/j.ctim.2022.102838 |